Commonly referred to as the Sunshine Act, the National Physician Payment Transparency Program was established as part of the Patient Protection and Affordable Care Act (ACA) and is intended to create greater transparency about the financial relationships between drug and device manufacturers and health care providers.
As part of the Centers for Medicare and Medicaid Services' (CMS) Open Payments program, industry is required to track and report payments to physicians and teaching hospitals. Dermatologists are also advised to track payments they receive from industry for verification purposes and to ensure accuracy of the posted information.
CMS will post the information that industry provides on the Open Payments public website, which anyone can access. Those in industry who do not comply can face penalties of $1 million or more.
Review the questions below to learn more about the program.